A Prospective Observational Study to Evaluate the Actual Use of 1% Pimecrolimus in Chinese Patients with Mild-to-Moderate Atopic Dermatitis Affecting Sensitive Skin Areas
This study provides robust real-world evidence that PIM 1% cream is effective for the treatment of mild-to-moderate AD in Chinese patients, particularly in sensitive skin areas and paediatric population. PIM also offers a TCS-sparing approach, making it a valuable option for managing mild-to-moderate AD.
Authors
- Chunping Shen (ORCID: https://orcid.org/0000-0002-6275-8541)
- Congxiu Ye (ORCID: https://orcid.org/0000-0002-6650-7651)
- Lin Ma (ORCID: https://orcid.org/0000-0001-7625-9842)
- Li Zhang (ORCID: https://orcid.org/0000-0001-5233-5708)
- Hua Wang
- Xia Dou (ORCID: https://orcid.org/0000-0001-9316-4466)
- Yue Zheng
- Ying Gao (ORCID: https://orcid.org/0000-0002-1413-3088)
- Qian An (ORCID: https://orcid.org/0000-0002-7504-6543)
- Jianmin Chang
- Zhiqiang Xie (ORCID: https://orcid.org/0000-0003-3388-7341)
Institutions
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Capital Institute of Pediatrics (CN)
- Peking University Shenzhen Hospital (CN)
- First Hospital of China Medical University (CN)
- Peking University Third Hospital (CN)
- Beijing Children’s Hospital (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Pragmatic and Observational Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/por.s496970
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00